resiquimod has been researched along with Lupus Erythematosus, Systemic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, A; Kumar, U; Malik, M; Pal, R; Sachdeva, R; Sharma, H | 1 |
| Du, D; Jiang, F; Li, Z; Miao, Y; Xie, Y; Yang, Y; Zhang, L; Zhou, L; Zhou, P; Zou, Z | 1 |
| Alcantar, TM; Anderson, K; Austin, CD; Bacarro, N; Dunlap, D; Eastham, J; Ghilardi, N; Hackney, J; Heredia, J; Hui, J; Katewa, A; Lafkas, D; Lee, WP; Liang, J; Modrusan, Z; Paler-Martinez, A; Rairdan, XY; Suto, E | 1 |
| Calise, J; Diamond, B; Gregersen, PK; Marquez Renteria, S | 1 |
| Caricchio, R; Corradetti, C; Gallo, PM; Gallucci, S; Ganea, D; Hooper, KM; Lee, MH | 1 |
| Burd, CJ; Friedman, AK; James, H; Jarjour, WN; Kaffenberger, BH; Rajaram, MV; Schlesinger, LS; Shupnik, MA; Wu, LC; Young, NA | 1 |
| Elkon, KB; Sontheimer, C | 1 |
| Fujimoto, C; Kamijima, R; Kataoka, S; Nakajima, K; Sano, S; Takaishi, M; Terada, Y; Yokogawa, M | 1 |
| Baechler, EC; Crabtree, JN; Ewart, D; Fazeli, P; Peterson, EJ; Wang, Y; Yamamoto, A | 1 |
| Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
| Arruda-Silva, F; Bianchetto-Aguilera, F; Calzetti, F; Cassatella, MA; Finotti, G; Lunardi, C; Scapini, P; Tamassia, N; Zimmermann, M | 1 |
11 other study(ies) available for resiquimod and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Haemoglobin drives inflammation and initiates antigen spread and nephritis in lupus.
Topics: Animals; Apoptosis; Autoantibodies; Autoantigens; Biomarkers; Cytokines; Dendritic Cells; Disease Susceptibility; Hemoglobins; Humans; Imidazoles; Leukocytes, Mononuclear; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Lymphocyte Subsets; Mice; Protein Binding; Signal Transduction; Spleen | 2022 |
TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
Topics: Animals; Apoptosis; B-Lymphocytes; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cytokines; Female; Imidazoles; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-kappa B; Piperazines; Spleen; Thiazoles; Toll-Like Receptor 7 | 2020 |
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Topics: Animals; Chemokines; Cytokines; Dendritic Cells; Imidazoles; Interferon-alpha; Lupus Erythematosus, Systemic; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Mice, Knockout; Survival Rate; Terpenes; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2021 |
Lineage-Specific Functionality of an Interferon Regulatory Factor 5 Lupus Risk Haplotype: Lack of B Cell Intrinsic Effects.
Topics: Adolescent; Adult; Apoptosis; Autoimmunity; B-Lymphocytes; Case-Control Studies; Cell Line; Female; Gene Expression; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Imidazoles; Interferon Regulatory Factors; Lupus Erythematosus, Systemic; Male; Middle Aged; Oligodeoxyribonucleotides; Risk Factors; Young Adult | 2018 |
The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus.
Topics: Animals; CD40 Antigens; Chemokine CXCL10; Dendritic Cells; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Imidazoles; Interferon Type I; Interleukin-10; Interleukin-27; Ligands; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Receptor, Interferon alpha-beta; Toll-Like Receptors | 2019 |
Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cells, Cultured; Endosomes; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation; Humans; Imidazoles; Immunologic Factors; Interferon-alpha; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Protein Binding; Sex Factors; Signal Transduction; Toll-Like Receptor 8 | 2014 |
Editorial: toll-like receptor 7: more than skin deep?
Topics: Aminoquinolines; Animals; Autoimmunity; Imidazoles; Imiquimod; Lupus Erythematosus, Systemic; Toll-Like Receptor 7 | 2014 |
Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Imidazoles; Imiquimod; Lupus Erythematosus, Systemic; Mice; Skin; Spleen; Toll-Like Receptor 7 | 2014 |
PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Topics: Adult; Animals; Case-Control Studies; Dendritic Cells; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Imidazoles; Interferon Type I; Interferon-alpha; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice, Transgenic; Middle Aged; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatase, Non-Receptor Type 22; STAT1 Transcription Factor; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha | 2015 |
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
IFNα enhances the production of IL-6 by human neutrophils activated via TLR8.
Topics: Adult; Aged; CCAAT-Enhancer-Binding Protein-beta; Cell Survival; Female; Gene Expression Profiling; Gene Expression Regulation; Genetic Loci; Humans; Imidazoles; Interferon-alpha; Interleukin-6; Lupus Erythematosus, Systemic; Middle Aged; Neutrophils; Promoter Regions, Genetic; Protein Binding; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Necrosis Factor-alpha; Young Adult | 2016 |